CN101220090A - 明胶多重改性衍生物及其交联材料 - Google Patents
明胶多重改性衍生物及其交联材料 Download PDFInfo
- Publication number
- CN101220090A CN101220090A CNA2007100362765A CN200710036276A CN101220090A CN 101220090 A CN101220090 A CN 101220090A CN A2007100362765 A CNA2007100362765 A CN A2007100362765A CN 200710036276 A CN200710036276 A CN 200710036276A CN 101220090 A CN101220090 A CN 101220090A
- Authority
- CN
- China
- Prior art keywords
- gelatin
- glutin
- solution
- modification derivant
- modification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012986 modification Methods 0.000 title claims abstract description 191
- 241001597008 Nomeidae Species 0.000 title claims description 151
- SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 title claims description 148
- 239000011243 crosslinked material Substances 0.000 title claims description 24
- 229920000159 gelatin Polymers 0.000 claims abstract description 171
- 235000019322 gelatine Nutrition 0.000 claims abstract description 169
- 239000008273 gelatin Substances 0.000 claims abstract description 168
- 108010010803 Gelatin Proteins 0.000 claims abstract description 166
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 166
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 37
- 125000001118 alkylidene group Chemical group 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 6
- 230000006798 recombination Effects 0.000 claims abstract description 5
- 238000005215 recombination Methods 0.000 claims abstract description 5
- -1 carboxyl sylvite Chemical compound 0.000 claims description 66
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- 229920001223 polyethylene glycol Polymers 0.000 claims description 17
- 239000002202 Polyethylene glycol Substances 0.000 claims description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000005647 linker group Chemical group 0.000 claims description 6
- CYWHLOXWVAWMFO-UHFFFAOYSA-N 3-sulfanyl-1h-pyridine-2-thione Chemical compound SC1=CC=CN=C1S CYWHLOXWVAWMFO-UHFFFAOYSA-N 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical class CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 claims description 4
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 4
- CGIHPACLZJDCBQ-UHFFFAOYSA-N acibenzolar Chemical compound SC(=O)C1=CC=CC2=C1SN=N2 CGIHPACLZJDCBQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 150000002466 imines Chemical class 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- AUHYZQCEIVEMFH-UHFFFAOYSA-N 2-bromopropanamide Chemical compound CC(Br)C(N)=O AUHYZQCEIVEMFH-UHFFFAOYSA-N 0.000 claims description 2
- NASRDENTZCCAPN-UHFFFAOYSA-N OC([Na])=O Chemical class OC([Na])=O NASRDENTZCCAPN-UHFFFAOYSA-N 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- PTSDHHWSSCWLTK-UHFFFAOYSA-N BrCCC(=O)NC(C(=O)N)(C)I Chemical compound BrCCC(=O)NC(C(=O)N)(C)I PTSDHHWSSCWLTK-UHFFFAOYSA-N 0.000 claims 1
- 230000004048 modification Effects 0.000 abstract description 43
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 42
- 239000000126 substance Substances 0.000 abstract description 36
- 230000002209 hydrophobic effect Effects 0.000 abstract description 9
- 239000011159 matrix material Substances 0.000 abstract description 3
- 230000010261 cell growth Effects 0.000 abstract description 2
- 230000021523 carboxylation Effects 0.000 abstract 2
- 238000006473 carboxylation reaction Methods 0.000 abstract 2
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 274
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 147
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 130
- 238000000502 dialysis Methods 0.000 description 93
- 238000003756 stirring Methods 0.000 description 86
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 76
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 68
- 238000006243 chemical reaction Methods 0.000 description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 56
- 230000006698 induction Effects 0.000 description 53
- 239000012535 impurity Substances 0.000 description 50
- 238000002360 preparation method Methods 0.000 description 49
- 238000010521 absorption reaction Methods 0.000 description 35
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 34
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 34
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 34
- 238000000034 method Methods 0.000 description 34
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- 238000002266 amputation Methods 0.000 description 24
- 239000012153 distilled water Substances 0.000 description 24
- 238000012856 packing Methods 0.000 description 24
- 239000007787 solid Substances 0.000 description 24
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- 239000002253 acid Substances 0.000 description 21
- 239000000499 gel Substances 0.000 description 20
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 19
- 238000007385 chemical modification Methods 0.000 description 18
- 125000003396 thiol group Chemical group [H]S* 0.000 description 17
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 15
- 239000000872 buffer Substances 0.000 description 14
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 14
- 239000002953 phosphate buffered saline Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 230000006242 butyrylation Effects 0.000 description 12
- 238000010514 butyrylation reaction Methods 0.000 description 12
- 239000000017 hydrogel Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 238000001228 spectrum Methods 0.000 description 12
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- 230000002378 acidificating effect Effects 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 125000004119 disulfanediyl group Chemical group *SS* 0.000 description 11
- 230000006872 improvement Effects 0.000 description 11
- 238000004811 liquid chromatography Methods 0.000 description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 150000008064 anhydrides Chemical class 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 239000013067 intermediate product Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229940099500 cystamine Drugs 0.000 description 7
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 150000008065 acid anhydrides Chemical class 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000012670 alkaline solution Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 125000004386 diacrylate group Chemical group 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000010382 chemical cross-linking Methods 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- RVEZZJVBDQCTEF-UHFFFAOYSA-N sulfenic acid Chemical compound SO RVEZZJVBDQCTEF-UHFFFAOYSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- JPSKCQCQZUGWNM-UHFFFAOYSA-N 2,7-Oxepanedione Chemical compound O=C1CCCCC(=O)O1 JPSKCQCQZUGWNM-UHFFFAOYSA-N 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 230000022244 formylation Effects 0.000 description 3
- 238000006170 formylation reaction Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 description 3
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 3
- QKSBEDINHRIOJR-UHFFFAOYSA-N 2-iodopropanamide Chemical compound CC(I)C(N)=O QKSBEDINHRIOJR-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- PKHMTIRCAFTBDS-UHFFFAOYSA-N hexanoyl hexanoate Chemical compound CCCCCC(=O)OC(=O)CCCCC PKHMTIRCAFTBDS-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- RAFYDKXYXRZODZ-UHFFFAOYSA-N octanoyl octanoate Chemical compound CCCCCCCC(=O)OC(=O)CCCCCCC RAFYDKXYXRZODZ-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- OEZPDHRXGCLGKB-UHFFFAOYSA-N 2-chloropropanamide Chemical compound CC(Cl)C(N)=O OEZPDHRXGCLGKB-UHFFFAOYSA-N 0.000 description 1
- WXUAQHNMJWJLTG-UHFFFAOYSA-N 2-methylbutanedioic acid Chemical compound OC(=O)C(C)CC(O)=O WXUAQHNMJWJLTG-UHFFFAOYSA-N 0.000 description 1
- 206010005908 Body temperature conditions Diseases 0.000 description 1
- QJSJOARSLDLKSX-UHFFFAOYSA-N C(C)(CC)OC(C(C)(C)C)OOCCCCC Chemical compound C(C)(CC)OC(C(C)(C)C)OOCCCCC QJSJOARSLDLKSX-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- WLJVNTCWHIRURA-UHFFFAOYSA-N Heptanedioic acid Natural products OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-N Suberic acid Natural products OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- LTAAMLJOTOUMFM-UHFFFAOYSA-N azane N-propan-2-ylprop-2-enamide Chemical compound N.C(C=C)(=O)NC(C)C LTAAMLJOTOUMFM-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- HDFRDWFLWVCOGP-UHFFFAOYSA-N carbonothioic O,S-acid Chemical group OC(S)=O HDFRDWFLWVCOGP-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical class OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N hexane carboxylic acid Natural products CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100362765A CN101220090B (zh) | 2007-01-09 | 2007-01-09 | 明胶多重改性衍生物及其交联材料 |
US12/522,476 US8158754B2 (en) | 2007-01-09 | 2007-09-29 | Multiple modified derivatives of gelatin and crosslinked material thereof |
PCT/CN2007/002863 WO2008083542A1 (fr) | 2007-01-09 | 2007-09-29 | Dérivés de gélatine multiples modifiés et leur matériau de réticulation |
EP07816477.9A EP2103662B1 (en) | 2007-01-09 | 2007-09-29 | Multiple modified derivatives of gelatin and crosslinked material thereof |
AU2007343561A AU2007343561B2 (en) | 2007-01-09 | 2007-09-29 | Multiple modified derivatives of gelatin and crosslinked material thereof |
JP2009545047A JP5357779B2 (ja) | 2007-01-09 | 2007-09-29 | 多重修飾されたゼラチン誘導体およびその架橋材料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100362765A CN101220090B (zh) | 2007-01-09 | 2007-01-09 | 明胶多重改性衍生物及其交联材料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101220090A true CN101220090A (zh) | 2008-07-16 |
CN101220090B CN101220090B (zh) | 2010-10-13 |
Family
ID=39608327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100362765A Active CN101220090B (zh) | 2007-01-09 | 2007-01-09 | 明胶多重改性衍生物及其交联材料 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8158754B2 (zh) |
EP (1) | EP2103662B1 (zh) |
JP (1) | JP5357779B2 (zh) |
CN (1) | CN101220090B (zh) |
AU (1) | AU2007343561B2 (zh) |
WO (1) | WO2008083542A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102020775A (zh) * | 2010-11-26 | 2011-04-20 | 浙江工业大学 | 一种改性明胶的制备方法 |
CN102924727A (zh) * | 2012-06-28 | 2013-02-13 | 中国科学院化学研究所 | 一种醛基改性明胶材料及其制备方法 |
CN103459418A (zh) * | 2011-03-30 | 2013-12-18 | 富士胶片株式会社 | 细胞粘附性蛋白 |
CN103725252A (zh) * | 2014-01-08 | 2014-04-16 | 四川省纺织科学研究院 | 一种无甲醛胶黏剂及其制备方法和应用 |
CN107929804A (zh) * | 2017-12-26 | 2018-04-20 | 常州百瑞吉生物医药有限公司 | 改性明胶基复合海绵及其制备方法和用途 |
CN112034159A (zh) * | 2020-09-06 | 2020-12-04 | 武汉生之源生物科技股份有限公司 | 一种凝胶化免疫磁珠及其制备方法与用途 |
CN114316167A (zh) * | 2022-01-24 | 2022-04-12 | 湖北沃德利派生物科技有限公司 | 可负载间充质干细胞上清液成分的可注射光增强自愈合水凝胶及其制备方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102399295B (zh) | 2010-09-09 | 2013-11-06 | 常州百瑞吉生物医药有限公司 | 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途 |
US8859735B2 (en) * | 2012-08-27 | 2014-10-14 | Empire Technology Development Llc | Gelatin alkyd peptides and uses thereof |
GB2596525A (en) * | 2020-06-26 | 2022-01-05 | Fujifilm Corp | Modified gelatins |
CN115389681B (zh) * | 2022-11-01 | 2023-01-20 | 常州百瑞吉生物医药有限公司 | 一种巯基化透明质酸衍生物中二硫苏糖醇残留的检测方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4055554A (en) * | 1976-09-10 | 1977-10-25 | National Starch And Chemical Corporation | Gel strength enhancer for gelatin compositions including an oxidized polysaccharide |
JPH0196200A (ja) * | 1987-10-06 | 1989-04-14 | Kanebo Ltd | 修飾ゼラチン |
JPH01144477A (ja) * | 1987-11-30 | 1989-06-06 | Kanebo Ltd | 修飾ゼラチン |
DE69314704T2 (de) * | 1992-06-29 | 1998-02-19 | Sterling Diagnostic Imaging | In Situ Modifizierung der Carboxylgruppen von Gelatin |
EP0576911A3 (en) * | 1992-06-29 | 1994-06-15 | Du Pont | In situ modification of gelatin amine groups |
US5620704A (en) * | 1994-11-07 | 1997-04-15 | Warner-Lambert Company | Process for stabilizing gelatin products |
DE19604706A1 (de) * | 1996-02-09 | 1997-08-14 | Merck Patent Gmbh | Vernetzungsprodukte von Aminogruppen-haltigen Biopolymeren |
JP4210023B2 (ja) * | 2000-08-09 | 2009-01-14 | 富士フイルム株式会社 | 修飾ゼラチン、その製造方法およびそれを含有するハロゲン化銀写真感光材料 |
JP4340067B2 (ja) * | 2001-04-23 | 2009-10-07 | ウィスコンシン アルムニ リサーチ ファウンデイション | 二機能性改変ハイドロゲル |
CA2489712C (en) * | 2002-06-21 | 2016-07-12 | University Of Utah Research Foundation | Crosslinked compounds and methods of making and using thereof |
EP1694712A1 (en) * | 2003-12-04 | 2006-08-30 | University of Utah Research Foundation | Modified macromolecules and methods of making and using thereof |
JP2006133365A (ja) * | 2004-11-04 | 2006-05-25 | Konica Minolta Medical & Graphic Inc | 熱現像感光材料及び熱現像感光材料の画像形成方法 |
JP2006349726A (ja) * | 2005-06-13 | 2006-12-28 | Konica Minolta Medical & Graphic Inc | 有機銀塩粒子の製造方法及び銀塩光熱写真ドライイメージング材料 |
CN101200504B (zh) * | 2006-12-11 | 2010-05-12 | 上海百瑞吉生物医药有限公司 | 高分子巯基化改性衍生物及其交联材料 |
-
2007
- 2007-01-09 CN CN2007100362765A patent/CN101220090B/zh active Active
- 2007-09-29 WO PCT/CN2007/002863 patent/WO2008083542A1/zh active Application Filing
- 2007-09-29 JP JP2009545047A patent/JP5357779B2/ja active Active
- 2007-09-29 US US12/522,476 patent/US8158754B2/en active Active
- 2007-09-29 AU AU2007343561A patent/AU2007343561B2/en active Active
- 2007-09-29 EP EP07816477.9A patent/EP2103662B1/en active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102020775A (zh) * | 2010-11-26 | 2011-04-20 | 浙江工业大学 | 一种改性明胶的制备方法 |
CN102020775B (zh) * | 2010-11-26 | 2012-05-16 | 浙江工业大学 | 一种改性明胶的制备方法 |
CN103459418A (zh) * | 2011-03-30 | 2013-12-18 | 富士胶片株式会社 | 细胞粘附性蛋白 |
CN102924727A (zh) * | 2012-06-28 | 2013-02-13 | 中国科学院化学研究所 | 一种醛基改性明胶材料及其制备方法 |
CN103725252A (zh) * | 2014-01-08 | 2014-04-16 | 四川省纺织科学研究院 | 一种无甲醛胶黏剂及其制备方法和应用 |
CN103725252B (zh) * | 2014-01-08 | 2016-04-20 | 四川省纺织科学研究院 | 一种无甲醛胶黏剂及其制备方法和应用 |
CN107929804A (zh) * | 2017-12-26 | 2018-04-20 | 常州百瑞吉生物医药有限公司 | 改性明胶基复合海绵及其制备方法和用途 |
CN112034159A (zh) * | 2020-09-06 | 2020-12-04 | 武汉生之源生物科技股份有限公司 | 一种凝胶化免疫磁珠及其制备方法与用途 |
CN112034159B (zh) * | 2020-09-06 | 2023-08-29 | 武汉生之源生物科技股份有限公司 | 一种凝胶化免疫磁珠及其制备方法与用途 |
CN114316167A (zh) * | 2022-01-24 | 2022-04-12 | 湖北沃德利派生物科技有限公司 | 可负载间充质干细胞上清液成分的可注射光增强自愈合水凝胶及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2007343561B2 (en) | 2014-04-17 |
JP2010515788A (ja) | 2010-05-13 |
CN101220090B (zh) | 2010-10-13 |
JP5357779B2 (ja) | 2013-12-04 |
EP2103662A1 (en) | 2009-09-23 |
EP2103662B1 (en) | 2015-11-11 |
US8158754B2 (en) | 2012-04-17 |
WO2008083542A1 (fr) | 2008-07-17 |
EP2103662A4 (en) | 2012-11-28 |
US20090306345A1 (en) | 2009-12-10 |
AU2007343561A1 (en) | 2008-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101220090B (zh) | 明胶多重改性衍生物及其交联材料 | |
CN101200504B (zh) | 高分子巯基化改性衍生物及其交联材料 | |
CA2466116C (en) | Synthetic matrix for controlled cell ingrowth and tissue regeneration | |
AU773914B2 (en) | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups | |
US6958212B1 (en) | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds | |
US8404223B2 (en) | Polymer | |
CN101631804A (zh) | 由疏水性氨基酸官能化的葡聚糖 | |
CZ296842B6 (cs) | Zesítené hyaluronové kyseliny | |
NZ220323A (en) | 3-dimensional network of microspheres containing biologically active macromolecular agents | |
KR20180046378A (ko) | 생체친화형 하이드로젤 및 제조방법 | |
JP2002541070A (ja) | メルカプト官能基をグラフトすることで改変したコラーゲンペプチド、それを得る方法および生体材料としてのその使用 | |
US20190256615A1 (en) | Site-selective modification of polysaccharides and applications thereof | |
CN113150313A (zh) | 一种中性溶解的改性光固化胶原的制备方法和光固化胶原水凝胶 | |
IL259891B1 (en) | Organic solvent-free compositions containing conjugates of protein and polymer, and their uses | |
CN101638462A (zh) | 一种聚(l-谷氨酸)/聚(n-异丙基丙烯酰胺)的水凝胶及制法 | |
US8507659B2 (en) | Method for chemically modifying biopolymer and polypeptide | |
EP0459624B1 (en) | Galactosamine-substituted poly-omega-substituted-L-glutamic and/or-aspartic acid | |
US20050238678A1 (en) | Hydrogels from biopolymers | |
CN105854075B (zh) | 一种基于甲基乙烯基醚马来酸共聚物/硫酸软骨素pH敏感复合水凝胶及其制备方法 | |
Mai | Synthesis and Characterisation of Peptide-Polymer Conjugate Hydrogels for Biomedical Applications | |
WO2008152475A2 (en) | Biocompatible polymers of bisacrylamides and amino acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGZHOU BIOREG BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI BAIRUIJI BIOLOGICAL MEDICAL CO., LTD. Effective date: 20110927 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200120 PUDONG NEW AREA, SHANGHAI TO: 213025 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110927 Address after: 213025 No. 167-5 Dongfang Dong Road, Jiangsu, Changzhou Patentee after: BIOREGEN BIOMEDICAL (CHANGZHOU) Co.,Ltd. Address before: 200120, room 33, No. 235, Lane 402, milk Hill Road, Shanghai, Pudong New Area Patentee before: Bioregen Biomedical (Changzhou) Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 213125 Jiangsu province Changzhou City New District Xue Ye Lu No. 117 block B Patentee after: BIOREGEN BIOMEDICAL (CHANGZHOU) Co.,Ltd. Address before: 213025 No. 167-5 Dongfang Dong Road, Jiangsu, Changzhou Patentee before: BIOREGEN BIOMEDICAL (CHANGZHOU) Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: 213000 block B, No. 117 Xueye Road, Xinbei District, Changzhou City, Jiangsu Province Patentee after: Changzhou Bairuiji Biopharmaceutical Co.,Ltd. Address before: 213125 building B, 117 Xueye Road, Xinbei District, Changzhou City, Jiangsu Province Patentee before: BIOREGEN BIOMEDICAL (CHANGZHOU) Co.,Ltd. |
|
CP03 | Change of name, title or address |